SCHEMBL2843073

SCHEMBL2843073

NP(O)OCCCCCCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21356075 0.98
SCHEMBL16581335 0.80
SCHEMBL11436590 0.80 TSHR (0.30)
SCHEMBL394606 0.78 DNM1 (0.40)
SCHEMBL8935552 0.76 HTT (0.41)
SCHEMBL2563068 0.76 HTT (0.41)
SCHEMBL27805552 0.76 HTT (0.41)
SCHEMBL9277188 0.76
SCHEMBL18704189 0.76 HTT (0.41)
SCHEMBL27805555 0.76 HTT (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270562-A1 BIS-RNAI COMPOUNDS FOR CNS DELIVERY BANK OF AMERICA, N.A. 2025-08-28 US disclosed
EP-4367237-A2 BIS-RNAI COMPOUNDS FOR CNS DELIVERY Alnylam Pharmaceuticals, Inc. (US) 2024-05-15 EP disclosed
US-20230257745-A1 Circular siRNAs BANK OF AMERICA, N.A. 2023-08-17 US disclosed
WO-2023283403-A2 BIS-RNAI COMPOUNDS FOR CNS DELIVERY ALNYLAM PHARMACEUTICALS, INC. (US) 2023-01-12 WO disclosed
WO-2022011214-A1 CIRCULAR SIRNAS ALNYLAM PHARMACEUTICALS, INC. (US) 2022-01-13 WO disclosed
CN-113631764-A Methods, compositions, and apparatus for solid state synthesis of scalable polymers for use in single molecule sequencing 斯特拉托斯基因公司 2021-11-09 CN disclosed
CN-106467913-B Probe inversion method for in situ synthesis of probe arrays 生捷科技控股公司 2021-07-20 CN disclosed
US-10695735-B2 Probe inversion process for in situ synthesized probe arrays CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2020-06-30 US disclosed
CN-106460232-B Oligonucleotide probe inversion method for in situ synthesized probe array 生捷科技控股公司 2019-12-24 CN disclosed
US-20190284619-A1 IN SITU PROBE INVERSION PROCESS FOR CONTSTRUCTING PROBE ARRAYS CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2019-09-19 US disclosed
US-20160258970-A1 SMALL MOLECULE-DEPENDENT SPLIT APTAMER LIGATION UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-09-08 US disclosed
EP-3049426-A1 GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS Centre National De La Recherche Scientifique (FR) 2016-08-03 EP disclosed
US-9279805-B2 Small molecule-dependent split aptamer ligation UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-03-08 US disclosed
WO-2015040209-A1 GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2015-03-26 WO disclosed
EP-2851371-A1 Glycoclusters and their pharmaceutical use as antibacterials Centre National de la Recherche Scientifique (CNRS) (FR) 2015-03-25 EP disclosed
US-20150072352-A1 SMALL MOLECULE-DEPENDENT SPLIT APTAMER LIGATION UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-03-12 US disclosed
US-8735367-B2 Small molecule-dependent split aptamer ligation UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2014-05-27 US disclosed
US-20130164739-A1 SMALL MOLECULE-DEPENDENT SPLIT APTAMER LIGATION UNIVERSITY OF UTAH 2013-06-27 US disclosed
US-8268977-B2 Strongly quenching oligomeric excimer/quencher pairs for detection schemes THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2012-09-18 US disclosed
US-20100129820-A1 STRONGLY QUENCHING OLIGOMERIC EXCIMER/QUENCHER PAIRS FOR DETECTION SCHEMES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-05-27 US disclosed